Does BEVACIZUMAB Cause Malignant neoplasm progression? 1,538 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,538 reports of Malignant neoplasm progression have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 2.0% of all adverse event reports for BEVACIZUMAB.
1,538
Reports of Malignant neoplasm progression with BEVACIZUMAB
2.0%
of all BEVACIZUMAB reports
579
Deaths
428
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BEVACIZUMAB?
Of the 1,538 reports, 579 (37.6%) resulted in death, 428 (27.8%) required hospitalization, and 54 (3.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 1,538 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BEVACIZUMAB Alternatives Have Lower Malignant neoplasm progression Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ